Evidence map›Paper›PMID 31165953›Full record

ArticleJournal of neuro-oncology2019

Correction to: Phase I-II trial of imatinib mesylate (Gleevec; STI571) in treatment of recurrent oligodendroglioma and mixed oligoastrocytoma. North central cancer treatment group study N0272 (ALLIANCE/NCCTG).

Kurt A Jaeckle, S K Anderson, Erin L Twohy, Jesse G Dixon, Caterina Giannini, Robert Jenkins, Merrill J Egorin, Jann N Sarkaria, Paul D Brown, P J Flynn and 3 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of neuro-oncology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Kurt A JaeckleMayo Clinic Florida, 4500 San Pablo Road, Jacksonville, FL, 32224, USA. jaeckle.kurt@mayo.edu.ORCID http://orcid.org/0000-0002-7827-463X
S K AndersonAlliance Statistics and Data Center, Mayo Clinic, Rochester, MN, USA.
Erin L TwohyAlliance Statistics and Data Center, Mayo Clinic, Rochester, MN, USA.
Jesse G DixonAlliance Statistics and Data Center, Mayo Clinic, Rochester, MN, USA.
Caterina GianniniMayo Clinic Rochester, Rochester, MN, USA.
Robert JenkinsMayo Clinic Rochester, Rochester, MN, USA.
Merrill J EgorinUniversity of Pittsburgh, Pittsburgh, PA, USA.
Jann N SarkariaMayo Clinic Rochester, Rochester, MN, USA.
Paul D BrownMayo Clinic Rochester, Rochester, MN, USA.
P J Flynn, Metro-Minnesota, St. Louis Park, MN, USA.
John Schwerkoske, Metro-Minnesota, St. Louis Park, MN, USA.
Jan C BucknerMayo Clinic Rochester, Rochester, MN, USA.
Evanthia GalanisMayo Clinic Rochester, Rochester, MN, USA.

Funding

Member Site CoreU10CA180821 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI Evanthia Galanis · 2014 to 2026
$177.3M
NCI NIH HHS U10 CA180821
6 · The paper itself

Abstract

The last author's first name was truncated in the initial online publication. The original article has been corrected.

Identifiers

PMID31165953
PMCPMC6739071

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.